Effects of Renal Artery Embolization Combined with Adrenal Hydrazone Tablets on Coagulation Function and Renal Function in Patients with Acute Renal Hemorrhage
返回论文页
|更新时间:2022-10-08
|
Effects of Renal Artery Embolization Combined with Adrenal Hydrazone Tablets on Coagulation Function and Renal Function in Patients with Acute Renal Hemorrhage
LI Wenfeng, GU Yufei, ZHANG Hui. Effects of Renal Artery Embolization Combined with Adrenal Hydrazone Tablets on Coagulation Function and Renal Function in Patients with Acute Renal Hemorrhage. [J]. 22(4):416-419(2022)
DOI:
LI Wenfeng, GU Yufei, ZHANG Hui. Effects of Renal Artery Embolization Combined with Adrenal Hydrazone Tablets on Coagulation Function and Renal Function in Patients with Acute Renal Hemorrhage. [J]. 22(4):416-419(2022) DOI: 10.14009/j.issn.1672-2124.2022.04.007.
Effects of Renal Artery Embolization Combined with Adrenal Hydrazone Tablets on Coagulation Function and Renal Function in Patients with Acute Renal Hemorrhage
OBJECTIVE: To probe into the effects of renal artery embolization combined with Adrenal hydrazone tablets on coagulation function and renal function in patients with acute renal hemorrhage. METHODS: A total of 61 patients with acute renal hemorrhage admitted into the Ninth People’s Hospital Affiliated to Shanghai Jiaotong University School of Medicine from Sept. 2019 to Sept. 2021 were selected and divided into the single treatment group(n=30) and the combined treatment group(n=31) via random number table. The single treatment group was treated with renal artery embolization
while the combined treatment group received renal artery embolization combined with Adrenal hydrazone tablets. The renal function of two groups was compared. Plasma prothrombin time(PT)
activated partial thrombin time(APTT) and fibrinogen(FIB) levels were determined by immunoturbidimetry
and tumor necrosis factor α(TNF-α)
interleukin(IL)-1 and IL-22 levels were determined by enzyme-linked immunosorbent assay. The treatment effects and incidence of complications were observed. RESULTS: After treatment
the levels of hematocrit and hemoglobin in the combined treatment group were higher than those in the single treatment group
and the heart rate was lower than that in the single treatment group
with statistically significant differences(P<0.05). After treatment
the levels of serum creatinine
24 h urine protein and blood urea nitrogen in the combined treatment group were lower than those in the single treatment group
the differences were statistically significant(P<0.05). After treatment
PT and APTT in the combined treatment group were longer than those in the single treatment group
and the levels of FIB
TNF-α
IL-1 and IL-22 were lower than those in the single treatment group
the differences were statistically significant(P<0.05). The total effective rate in the combined treatment group was 96.77%(30/31)
higher than 76.67%(23/30) in the single treatment group; the incidence of complications in the combined treatment group was 3.23%(1/31)
lower than 20.00%(6/30) in the single treatment group
the difference was statistically significant(P<0.05). CONCLUSIONS: Renal arterial embolization combined with Adrenal hydrazone tablets in the treatment of acute renal hemorrhage can improve the renal function and the coagulation function
effectively regulate the inflammatory reaction
with remarkable therapeutic effects.
关键词
急性肾出血肾动脉栓塞术肾上腺色腙片肾功能凝血功能
Keywords
Acute renal hemorrhageRenal artery embolizationAdrenal hydrazone tabletsRenal functionBlood coagulation function
Progress of Kidney Function-Based Clinical Decision Support System for Rational Drug Use
Dynamic Analysis on Effects of Levosimendan Combined with Dopamine on Cardiac and Renal Function in Patients with Acute Heart Failure Based on DID Model
Effect of Configuration Concentration and Patient’s Basic Renal Function on the Safety of Vancomycin
Effect of Zhibitai Capsule for Intensive Lipid-Lowering on Carotid Plaque and Serum Inflammatory Factor in Patients with Recovery Phase of Cerebral Infarction Complicated with Carotid Plaque
Related Author
CHEN Mengli
LI Chen
WANG Jin
GU Yang
ZHANG Xin
WU Shen
YU Longze
PENG Zhao
Related Institution
Medical School of Chinese PLA
Dept.of Pharmacy, Chinese PLAGeneral Hospital
Center of TranslationalMedicine Research, Chinese PLA General Hospital
Dept. of Cardiovascular Medicine, Huai’an First People’s Hospital/the Affiliated Huai’an No.1 Hospital of Nanjing Medical University
Dept.of Pharmacy, Medical Security Center, General Hospital of PLA